Atrial Fibrillation Recurrence After Cryoballoon Ablation
Mechanisms and Patterns of Atrial Fibrillation Recurrence After Cryoballoon Ablation
1 other identifier
interventional
15
1 country
2
Brief Summary
The purpose of the study is to evaluate the mechanisms of recurrent atrial fibrillation after cryoballoon ablation using the Arctic Front Ablation System. For those with pulmonary vein reconnection, specific sites of reconnection will be evaluated with left atrial intracardiac echo (ICE) guidance. The Achieve mapping catheter will be evaluated head-to-head with our current method of ICE-guided recordings from a conventional mapping catheter with high output pulmonary venous pacing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable atrial-fibrillation
Started Jan 2013
Longer than P75 for not_applicable atrial-fibrillation
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 16, 2013
CompletedFirst Posted
Study publicly available on registry
January 21, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 7, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 7, 2019
CompletedFebruary 12, 2020
February 1, 2020
6.6 years
January 16, 2013
February 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence or absence of pulmonary vein isolation or reconnection
During repeat cryoballoon ablation procedure
Study Arms (1)
Recurrent Atrial Fibrillation
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Patients undergoing re-do catheter ablation procedure after index procedure with cryoballoon ablation
- At least 18 years old
- Able to read and understand informed consent
You may not qualify if:
- Unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- Medtroniccollaborator
Study Sites (2)
UPMC Presbyterian Shadyside
Pittsburgh, Pennsylvania, 15213, United States
UPMC Passavant
Pittsburgh, Pennsylvania, 15237, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandeep K Jain, MD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine, Cardiac Electrophysiology, University of Pittsburgh
Study Record Dates
First Submitted
January 16, 2013
First Posted
January 21, 2013
Study Start
January 1, 2013
Primary Completion
August 7, 2019
Study Completion
August 7, 2019
Last Updated
February 12, 2020
Record last verified: 2020-02